9 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18478261 | COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL OR MITOCHONDRIAL DISEASES | SZNAIDMAN, MARCOS L | 1628 | Non-Final OA | Sep 29, 2023 |
| 18449091 | DEVICE, SYSTEM AND METHOD FOR MONITORING NEUROLOGICAL FUNCTIONAL STATUS | CERIONI, DANIEL LEE | 3791 | Final Rejection | Aug 14, 2023 |
| 18259640 | AN AGR2Xcd3 BISPECIFIC ENGAGER FOR THE TREATMENT OF CANCER | CHHAY, BONIRATH | 1645 | Non-Final OA | Jun 28, 2023 |
| 18247519 | Advanced Cell-Permeable Peptide Carriers | PAULUS, ERIN VIRGINIA | 1631 | Non-Final OA | Mar 31, 2023 |
| 18191314 | MONITORING NEUROLOGICAL FUNCTIONAL STATUS | NGUYEN, HUONG Q | 3791 | Final Rejection | Mar 28, 2023 |
| 18155587 | G9A INHIBITION DECREASES STRESS-INDUCED AND DEPENDENCE-INDUCED ESCALATION OF ALCOHOL DRINKING | HIRAKIS, SOPHIA P | 1623 | Non-Final OA | Jan 17, 2023 |
| 18000011 | NONINVASIVE CRANIAL NERVE THERAPY | WEBSTER, KARMEL JOHANNA | 3792 | Final Rejection | Nov 28, 2022 |
| 17817125 | PROCESSES FOR GENERATING SUPERIOR ANTI-TUMOR T-CELL EFFECTOR AND MEMORY CELLS | RAHMAN, MASUDUR | 1633 | Final Rejection | Aug 03, 2022 |
| 17782611 | RNAi-BASED TARGETING COMPOUNDS AND USES THEREOF TO PREVENT ACQUIRED HEARING LOSS | GIBBS, TERRA C | 1635 | Final Rejection | Jun 03, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial